J. Reis-Filho
Cancer Research · 2005–2022
A researcher in the Science corpus: 24 papers; trusts 5 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Cancer Research — 316 citations into it; #1,388 of 1,780 by trust here, #162 by citations
- Molecular Biology — 225 citations into it
- Oncology — 217 citations into it; #1,386 of 1,698 by trust here, #442 by citations
- Genetics — 158 citations into it
- Pathology and Forensic Medicine — 126 citations into it
Whom J. Reis-Filho trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Charles M. Perou
- N. Turner
- Lisa A. Carey
- Torsten O. Nielsen
- Dalia M. Abd El‐Rehim
- W. Foulkes
- Robert Tibshirani
Who trusts J. Reis-Filho overall
Papers from J. Reis-Filho's perspective
Ordered by how strongly the researchers J. Reis-Filho trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular portraits of human breast tumours (Nature)
- Repeated observation of breast tumor subtypes in independent gene expression data sets (Proceedings of the National Academy of Sciences of the United States of America)
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (Proceedings of the National Academy of Sciences of the United States of America)
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (Journal of the American Medical Association (JAMA))
- Expert Commentary. (Histopathology)
- Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (Journal of the National Cancer Institute)
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Diagnosis of multiple cancer types by shrunken centroids of gene expression
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Archives of Pathology & Laboratory Medicine)
Their papers
- BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. (2010) — 792 citations
- The landscape of cancer genes and mutational processes in breast cancer (2012) — 1,739 citations
- International network of cancer genome projects (2010) — 2,229 citations
- Resistance to therapy caused by intragenic deletion in BRCA2 (2008) — 1,036 citations
- COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES (2009) — 860 citations
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF (2010) — 1,454 citations
- Gene expression profiling in breast cancer: classification, prognostication, and prediction. (2011) — 731 citations
- FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (2010) — 695 citations
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants (2019) — 647 citations
- The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers (2018) — 851 citations
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. (2022) — 650 citations
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. (2020) — 1,018 citations
- ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. (2019)
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer (2015) — 1,077 citations
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma (2015) — 753 citations
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. (2015) — 2,798 citations
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. (2014) — 779 citations
- Supplementary Figure S3 (2012) — 358 citations
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (2011) — 704 citations
- Triple-negative breast cancer. (2010) — 1,950 citations